Type 2 diabetes mellitus—current therapies and the emergence of surgical options
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type 2 diabetes mellitus—current therapies and the emergence of surgical options
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 7, Issue 7, Pages 408-419
Publisher
Springer Nature
Online
2011-02-08
DOI
10.1038/nrendo.2011.10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus
- (2013) Marion L. Vetter ANNALS OF INTERNAL MEDICINE
- Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control
- (2013) Helena Rodbard et al. Endocrine Practice
- Long-Term Follow-up of the Metabolic Profiles in Obese Patients With Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass
- (2010) Seongmin Kim et al. ANNALS OF SURGERY
- Metabolic Surgery to Treat Type 2 Diabetes: Clinical Outcomes and Mechanisms of Action
- (2010) Francesco Rubino et al. Annual Review of Medicine
- The effect of bariatric surgery on gut hormones that alter appetite
- (2010) D.-J. Pournaras et al. DIABETES & METABOLISM
- Medical follow up after bariatric surgery: nutritional and drug issues General recommendations for the prevention and treatment of nutritional deficiencies
- (2010) O. Ziegler et al. DIABETES & METABOLISM
- Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
- (2010) D. J. Drucker et al. DIABETES CARE
- Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
- (2010) J. M. Gaziano et al. DIABETES CARE
- DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
- (2010) J. B. Buse et al. DIABETES CARE
- Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial
- (2010) M. C. Riddle et al. DIABETES CARE
- Correlates of Insulin Injection Omission
- (2010) M. Peyrot et al. DIABETES CARE
- Relationship of baseline HbA1cand efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials
- (2010) R. A. DeFronzo et al. DIABETIC MEDICINE
- Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
- (2010) Craig J Currie et al. LANCET
- Adjunct therapy for type 1 diabetes mellitus
- (2010) Harold E. Lebovitz Nature Reviews Endocrinology
- Regulatory Action on Rosiglitazone by the U.S. Food and Drug Administration
- (2010) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy
- (2010) Mary Parks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revisiting the Rosiglitazone Story — Lessons Learned
- (2010) Clifford J. Rosen NEW ENGLAND JOURNAL OF MEDICINE
- Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
- (2009) Henry Buchwald et al. AMERICAN JOURNAL OF MEDICINE
- Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
- (2009) David D. Dore et al. CURRENT MEDICAL RESEARCH AND OPINION
- Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
- (2009) P. D. Reaven et al. DIABETES
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
- (2009) R. A. DeFronzo DIABETES
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration
- (2009) B. Staels et al. DIABETES CARE
- Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes
- (2009) L. M. Thorn et al. DIABETES CARE
- Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus
- (2009) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- Improvements in risk factor control among persons with diabetes in the United States: Evidence and implications for remaining life expectancy
- (2009) Thomas J. Hoerger et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Diabetes and cancer
- (2009) Paolo Vigneri et al. ENDOCRINE-RELATED CANCER
- Hormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery
- (2009) Joshua P. Thaler et al. ENDOCRINOLOGY
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial
- (2009) Lars Sjöström et al. LANCET ONCOLOGY
- Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
- (2009) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensive versus Conventional Glucose Control in Critically Ill Patients
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- The Gut Hormone Response Following Roux-en-Y Gastric Bypass: Cross-sectional and Prospective Study
- (2009) Dimitrios J. Pournaras et al. OBESITY SURGERY
- Relationship between surgeon volume and adverse outcomes after RYGB in Longitudinal Assessment of Bariatric Surgery (LABS) study
- (2009) Mark D. Smith et al. Surgery for Obesity and Related Diseases
- Gastric Banding or Bypass? A Systematic Review Comparing the Two Most Popular Bariatric Procedures
- (2008) Jeffrey A. Tice et al. AMERICAN JOURNAL OF MEDICINE
- Recommended Nutritional Supplements for Bariatric Surgery Patients
- (2008) Margaret Malone ANNALS OF PHARMACOTHERAPY
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- Use of Thiazolidinediones and Fracture Risk
- (2008) Christian Meier et al. ARCHIVES OF INTERNAL MEDICINE
- Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: A meta-analysis of observational studies
- (2008) A. D. Rao et al. DIABETES CARE
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
- (2008) M. Nauck et al. DIABETES CARE
- Primary care physician beliefs about insulin initiation in patients with type 2 diabetes
- (2008) R. P. Hayes et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes
- (2008) John B. Dixon et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bariatric Surgery: Risks and Rewards
- (2008) Walter J. Pories JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Weight Loss by Gastric Bypass SurgeryVersusHypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 Diabetes
- (2008) Blandine Laferrère et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Why Don’t Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification
- (2008) Julie A. Schmittdiel et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
- Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
- (2008) Alan Garber et al. LANCET
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- (2008) Peter Gæde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
- An overview of pancreatic beta-cell defects in human type 2 diabetes: Implications for treatment
- (2007) Piero Marchetti et al. REGULATORY PEPTIDES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More